Metabolic Protocol • ICD-10 E11.9
Type 2 Diabetes & Insulin Resistance
Progressive skeletal muscle and hepatic insulin resistance paired with pancreatic beta-cell secretory exhaustion requiring multi-pathway glycemic and cardiorenal protection.
Medically Reviewed by Dr. Elena Vance, MD, FACE (NPI #1043218901)
Type 2 Diabetes & Insulin Resistance Optimal Biomarker & Diagnostic Fact Matrix
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Classification | E11.9 | WHO / CMS ICD-10-CM Clinical Modification |
| Biomarker: HbA1c | < 5.7% (remission target) | DotMD Preventive Optimal Target Range |
| Biomarker: Continuous Glucose Time-in-Range | > 85% (70–140 mg/dL) | DotMD Preventive Optimal Target Range |
| Biomarker: Urine Albumin-to-Creatinine Ratio | < 10 mg/g | DotMD Preventive Optimal Target Range |
| Biomarker: C-Peptide (Fasting) | 0.8 – 2.2 ng/mL | DotMD Preventive Optimal Target Range |
Pathophysiology & Clinical Presentation
Defective GLUT4 translocation in myocytes and unrestrained hepatic gluconeogenesis coincide with islet amyloid deposition, lipotoxicity, and renal SGLT2 hyper-reabsorption of filtered glucose.
Hallmark Clinical Signs & Biomarker Triggers
- Persistent fasting plasma glucose >= 126 mg/dL
- Polyuria, polydipsia, and nocturnal osmotic diuresis
- Microvascular paresthesia in distal extremities
- Delayed cutaneous wound healing
Evidence-Based Medications & Cash Arbitrage for Type 2 Diabetes & Insulin Resistance
| Medication | Mechanism Class | Worth-It Score | Retail Avg | Lowest Cash |
|---|---|---|---|---|
| Tirzepatide Mounjaro, Zepbound | Dual GIP / GLP-1 Receptor Co-Agonist | 93.80% (38) | $1086.00 | $349.00/mo |
| Semaglutide Ozempic, Wegovy, Rybelsus | GLP-1 Receptor Agonist | 89.40% (42) | $1048.00 | $245.00/mo |
| Metformin Hydrochloride Glucophage, Glucophage XR, Fortamet | Biguanide AMPK & Mitochondrial Complex I Modulator | 88.10% (51) | $24.00 | $5.40/mo |
| Dapagliflozin Farxiga | Proximal Tubular SGLT2 Inhibitor | 87.90% (17) | $584.00 | $38.20/mo |
| Empagliflozin Jardiance | Selective Renal SGLT2 Inhibitor | 86.50% (19) | $612.00 | $115.00/mo |
| Acarbose Precose | Intestinal Alpha-Glucosidase & Pancreatic Alpha-Amylase Inhibitor | 83.40% (21) | $64.00 | $11.80/mo |
| Canagliflozin Invokana | Dual Renal SGLT2 & Low-Potency Intestinal SGLT1 Inhibitor | 81.00% (11) | $628.00 | $142.00/mo |
| Pioglitazone Hydrochloride Actos | Thiazolidinedione PPAR-Gamma Nuclear Agonist | 80.50% (14) | $48.00 | $6.90/mo |
| Sitagliptin Phosphate Januvia | Selective Dipeptidyl Peptidase-4 (DPP-4) Inhibitor | 79.00% (12) | $542.00 | $26.40/mo |
| Liraglutide Victoza, Saxenda | Daily Acylated GLP-1 Receptor Agonist | 78.20% (16) | $589.00 | $210.00/mo |
| Linagliptin Tradjenta | Non-Renally Cleared Xanthine DPP-4 Inhibitor | 77.40% (9) | $538.00 | $98.00/mo |
INSTANT PRESCRIPTION & CASH ROUTING
DotMD Club Members get $29 flat-rate script renewals →
Verified Online Prescribers & Wholesale Pharmacies for Type 2 Diabetes & Insulin Resistance
Ro Body & Metabolic Clinic (Online Doctor Consult + Delivery)
Asynchronous physician review included • Ships in ~2 days
$
45.00
Consult / Starting Tier
AgelessRx Geroprotective Telehealth (Online Doctor Consult + Delivery)
Asynchronous physician review included • Ships in ~3 days
• Rx included in monthly tier
$
65.00
All-In Monthly
Sesame Direct Cash-Pay Prescriber Network (Online Doctor Consult + Delivery)
Asynchronous physician review included • Ships in ~1 days
$
29.00
Consult / Starting Tier